Skip to content
Register Sign in Wishlist

Progress in Neurotherapeutics and Neuropsychopharmacology

Volume 1. 2006

$54.00 USD

J. L. Cummings, S. Tekin, R. Lane, B. Stankoff, C. Lubetzki, M. Clanet, W. P. Mason, R. O. Mirimanoff, R. Stupp, N. J. Wiendels, M. D. Ferrari, P. H. Gordon, J. Choi, D. H. Moore, R. G. Miller, J. M. Shefner, L. E. Pope, E. Hollander, E. Swanson, E. Anagnostou, A. Phillips, W. Chaplin, S. Wasserman, H. Y. Meltzer, A. Lin, A. Bodkin, D. C. Turner, B. J. Sahakian, G. M. Simpson, A. Loebel, L. Warrington, R. Yang
View all contributors
  • Date Published: January 2011
  • availability: This ISBN is for an eBook version which is distributed on our behalf by a third party.
  • format: Adobe eBook Reader
  • isbn: 9780511839740

$ 54.00 USD
Adobe eBook Reader

You will be taken to ebooks.com for this purchase
Buy eBook Add to wishlist

Other available formats:
Hardback, Paperback


Looking for an inspection copy?

This title is not currently available on inspection

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.

    • Annual update on clinical trials in neurotherapeutics and psychopharmacology
    • Editor, editorial board and contributors are all leading international figures
    • Provides the evidence on which to base treatments
    • Essential resource for clinicians and neuroscientists
    Read more

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: January 2011
    • format: Adobe eBook Reader
    • isbn: 9780511839740
    • availability: This ISBN is for an eBook version which is distributed on our behalf by a third party.
  • Table of Contents

    Preface J. L. Cummings
    Introduction to neurotherapeutics and neuropharmacology J. L. Cummings
    1. Rivastigmine in the treatment of dementia associated with Parkinson's disease: a randomized, double-blind, placebo-controlled study S. Tekin and R. Lane
    2. Modafinil for the treatment of fatigue in multiple sclerosis B. Stankoff, C. Lubetzki and M. Clanet
    3. Radiotherapy with concurrent and adjuvant temozolomide: a new standard of care for glioblastoma multiform W. P. Mason, R. O. Mirimanoff and R Stupp
    4. Treating migraine attacks ASAP: concept and methodological issues N. J. Wiendels and M. D. Ferrari
    5. Early phase trials of minocycline in amyotropic lateral sclerosis P. H. Gordon, J. Choi, D. H. Moore and R. G. Miller
    6. Creatine as a potential treatment for amyotrophic lateral sclerosis J. M. Shefner
    7. AVP-923 as a novel treatment for pseudobulbar affect ALS L. E. Pope
    8. Liquid fluoxetine vs. placebo for repetitive behaviors in childhood autism E. Hollander, E. Swanson, E. Anagnostou, A. Phillips, W. Chaplin and S. Wasserman
    9. Testing multiple novel mechanisms for treating schizophrenia in a single trial H. Y. Meltzer
    10. Selegiline in the treatment of negative symptoms of schizophrenia A. Lin and A. Bodkin
    11. Analysis of the cognitive enhancing effects of modafinil in schizophrenia D. C. Turner and B. J. Sahakian
    12. Efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatient with schizophrenia or schizoaffective disorder: results of a double-blind, 6-week study, with a 6-month, double-blind, continuation phase G. M. Simpson, A. Loebel, L. Warrington and R. Yang.

  • Editor

    Jeffrey L. Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health

    Contributors

    J. L. Cummings, S. Tekin, R. Lane, B. Stankoff, C. Lubetzki, M. Clanet, W. P. Mason, R. O. Mirimanoff, R. Stupp, N. J. Wiendels, M. D. Ferrari, P. H. Gordon, J. Choi, D. H. Moore, R. G. Miller, J. M. Shefner, L. E. Pope, E. Hollander, E. Swanson, E. Anagnostou, A. Phillips, W. Chaplin, S. Wasserman, H. Y. Meltzer, A. Lin, A. Bodkin, D. C. Turner, B. J. Sahakian, G. M. Simpson, A. Loebel, L. Warrington, R. Yang

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email lecturers@cambridge.org

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×